SNTI Stock Analysis: Buy, Sell, or Hold?
SNTI - Senti Biosciences, Inc. Common Stock
$1.01
0.01 (1.00%)
▲
5d:
-3.81%
30d:
-2.88%
90d:
-52.36%
BUY
HIGH Confidence
Last Updated: February 2, 2026
Earnings: Mar 19, 2026
Get Alerted When SNTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SNTI shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: SNTI shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: SNTI is currently trading at $1.01, which is considered oversold relative to its 30-day fair value range of $1.03 to $1.11.
Technical Outlook: Technically, SNTI is in a downtrend. Immediate support is located at $0.95, while resistance sits at $1.19.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.50 (+1038.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SNTI is in a downtrend. Immediate support is located at $0.95, while resistance sits at $1.19.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.50 (+1038.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.03 -
$1.11
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1038.6% below Wall St target ($11.50)
Fair Price Analysis
30-Day Fair Range
$1.03 -
$1.11
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.95
Resistance Level
$1.19
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.73
Wall Street Target
$11.50
(+1038.6%)
Revenue Growth (YoY)
-100.0%
Last updated: February 03, 2026 7:37 AM ET
Data refreshes hourly during market hours. Next update: 8:37 AM
Data refreshes hourly during market hours. Next update: 8:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$514 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 62 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$847 | 54 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 62 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 53 HOLD |
